
Mohammad Alomari, MD
@Alomari_MD
Followers
395
Following
395
Media
6
Statuses
181
🇯🇴IBD Provider @UAMS_GIHep Advanced IBD Fellow @ClevelandClinic Alum GI Fellow/Chief @CleveClinicFL IM Chief @ETSU IM Resident/Chief @ Fairview hospital
Little Rock, AR
Joined August 2021
Comparative effectiveness of tofacitinib versus upadacitinib for the treatment of acute severe ulcerative colitis - Clinical Gastroenterology and Hepatology
cghjournal.org
Tofacitinib and upadacitinib are Janus kinase (JAK) inhibitors that are increasingly used for the treatment of acute severe ulcerative colitis (ASUC). However, comparative analyses of safety and...
1
21
34
📢JUST IN! Global Consensus Statement on the Management of Pregnancy in Inflammatory Bowel Disease Mahadevan, et al. 📕 https://t.co/OfCC2PJS7G
@UmaMahadevanIBD @EdBarnesMD @DrEmmaFlanagan @sonia_friedman @JulsgaardMette @SunandaKaneMD @Siew_C_Ng @JoanaTo62523004 @CRobinsonMFM
1
51
99
🔥 Out today! @AmCollegeGastro Clinical Guideline Update: Preventive Care in #IBD 👥 @FarrayeIBD @gym99 @PennIBDDoc @EdBarnesMD @berkeleydoc @dr_fcalderaibd @SunandaKaneMD 👉 https://t.co/jVehC1enDH
0
47
130
Internal Medicine Grand Rounds “Emerging strategies for colorectal cancer screening” By one of our GI faculty Dr. Thomas Augustine @UAMS_COM @uamshealth @MaugarMD @Alomari_MD @genesisdelnogal @mk_gangwani @AdalGuzmanMD
1
2
16
Very proud to share a milestone for @uams_GIHep by having the only IBD program in the state with a certificate IBUS superstar @Alomari_MD Way to go!!! @uamshealth
4
2
26
Happy to share that I am now fully @BowelUltrasound certified on the use of intestinal ultrasound in IBD! Very grateful to the support and guidance of amazing mentors! Dr. Carla Nash @KrugCleveland @CathyLuMD @MaugarMD @uams_GIHep
15
4
60
Proud of our fellows who presented their research on the last day of #DDW2025
@genesisdelnogal @AdalGuzmanMD
@UAMS_COM
0
2
16
Our second year fellow @genesisdelnogal presenting her research mentored by @Alomari_MD
#UAMSProud
@DDWMeeting #DDW2025
0
1
10
Amazing year with the @MilestoneIBD class of 2025! Congratulations to the future of #IBD. Thank you to all our faculty and sponsors. Onwards and upwards. @tinahamd @DrsMeena @IBDBen @MRegueiroMD @DocCohenIBD @BristorCarrie @ManuelBragaMD @JosephHabibi_MD @IBD_GorenMD
0
18
75
#DDW2025 has been an incredible experience for everyone! The UAMS team hosted a wonderful dinner to reconnect with alumni, fellows, and old friends. Big thanks to our Division Chief for making this memorable evening possible! @MaugarMD
@DDWMeeting
0
4
33
The Difficult Colonoscopy is humbling to all endoscopists. My Pearls : #1 Female Patients If hysterectomy or diverticulitis, use pedi colonoscope + water immersion. (Angulated colon) If chronic idiopathic constipation or visceral obese, use adult colonoscope (redundant colon)
25
163
629
The treatment landscape for moderate to severe #IBD is evolving fast! Join us at #AIBDRegionals in Nashville (April 5-6) for expert insights from @HorstIBDDoc on the latest biologics & small molecules. Don’t miss this session!
0
2
5
Our very own, Dr. Alomari, demonstrates a commitment to ongoing education as he enhances his skill set in Intestinal Ultrasound in IBD, completing his IBUS Module 2 in British Columbia, Canada @Alomari_MD @uamshealth .
0
3
38
Proud of our team at @uams_GIHep
@AdalGuzmanMD @SDK2011 @genesisdelnogal having multiple abstracts accepted at @DDWMeeting 2025, see you at San Diego! @MaugarMD #GITwitter
1
5
30
🆕 @AmerGastroAssn Guidelines for Prevention & Treatment of Hepatitis B Virus Reactivation in At-Risk Individuals ▪️HBsAg (+) ▪️HBsAg (-), HBcAB (+) 🚨B-cell depleting agents 🚨Anthracycline 🚨Anti-TNF 🚨Anti-IL6 🚨Cytokine inh 🚨CAR-T 🚨TACE 🚨JAKi 🔗 https://t.co/WNTXJ09Cll
0
113
266
🔥🔊@AmerGastroAssn Clinical Practice Update on Healthcare Maintenance in #IBD
@AGA_CGH @dr_fcalderaibd @SunandaKaneMD and @MLongMD 🔎🩻🔬Age appropriate screening 💉🦠Vaccinations 🦴Bone Health 🧠Mental Health 🩼Treatment and Disease monitoring 🚫🚬 https://t.co/o1RqoKUMpJ
4
59
127
🚨News Alert 🚨 💥 Bezlotoxumab (Zinplava) to be discontinued by Merck effective Jan 31 (monoclonal antibody for secondary prevention of C Difficile Infection). @Khanna_S
@pfmets @DrStollman @tony_breu
@gonzalobearman @AmCollegeGastro @IDSAFoundation
https://t.co/NdRmzeyLlu
pharmalive.com
According to the FDA's website, the company will discontinue its drug for a bacterial infection that can lead to fatal diarrhea.
4
6
18